English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
Psychedelics for PTSD: Real Stories of Healing With MDMA and Ayahuasca
The first time Nathan closed his eyes during the trial, he described it like a kid pulling back heavy curtains in a room he’d been afraid of for years. He wasn’t scared anymore. He was curious. That single shift — from dread to curiosity — is something I hear over and over from people who turn to psychedelics for PTSD, and it’s usually where the real work begins. Stories like Nathan’s are part of why interest in psychedelic-assisted therapy has gone from fringe to front-page. MDMA, psilocybin, ayahuasca, ibogaine — none of them are silver bullets, and anyone honest in this field will tell you that. But a growing body of research, plus thousands of personal accounts, suggests these compounds can do something traditional treatment often can’t: help a traumatized nervous system feel safe enough to actually process what happened. Below are several real accounts — drawn from veterans, survivors, and clinical-trial participants — of what it actually feels like to face PTSD with the help of plant medicine and psychedelics. I’ve sat with people during and after experiences like these. The patterns repeat. The details never do. PTSD is stubborn. SSRIs help some people a little. Talk therapy helps more people, but slowly, and not everyone. For combat veterans, sexual assault survivors, and people carrying the weight of childhood trauma, the standard menu can feel exhausted before they’ve really started. That’s where psychedelics — and the broader category of master plants — keep entering the conversation. The research is genuinely promising. MDMA-assisted therapy is in late-stage clinical trials with MAPS, and early data has been strong enough that the FDA granted it Breakthrough Therapy designation. Psilocybin is being studied for treatment-resistant depression, end-of-life anxiety, and trauma. Ayahuasca, traditionally brewed in the Amazon for centuries, has drawn veterans’ groups who travel to legal jurisdictions because they’ve simply run out of options at home. None of this means you should go book a flight tomorrow. It does mean the desperation a lot of trauma survivors feel — that nothing is working — is finally being met with serious science and serious facilitators. The question is whether a retreat or trial is the right fit for you, right now. One former special-operations sergeant I’ll call C., 37, spent sixteen years in the military. By the time she got her PTSD diagnosis, she was preparing for another deployment and quietly aware she was no longer fit to lead her team. Antidepressants didn’t move the needle. Rehab helped with the drinking. The trauma itself — childhood and what came later in uniform — sat untouched. She heard about ayahuasca on a podcast, fell down the research rabbit hole, and eventually ended up at a retreat in Mexico that combined psilocybin and MDMA in a ceremonial setting. Lying among other participants, eye mask on, music playing, her body started shaking — not from fear, she said, but from something almost warm. Her chest felt like it was being held open. What she keeps coming back to isn’t the visions. It’s the absence of shame. For a few hours she existed without the constant low hum of guilt that had followed her for decades. That’s not a cure. But for someone who’d forgotten what neutral even felt like, it was the first crack of daylight. Another veteran, a former paralegal and combat driver, joined a retreat in 2021 after a year of talk therapy and several months of one-on-one prep with a coach. The retreat itself required strict dieta beforehand — no caffeine, no sugar, no alcohol, no salt, no stimulants. Participants journaled. They talked in circles. They got clear on what they were actually there for. She described the ceremony as drifting in and out of consciousness. When she came to, she felt the brew moving inside her — up to her throat, down through her stomach, swirling in her pelvis. She kept repeating, quietly, thank you for healing me, thank you for showing me, for what she remembers as about four hours. She’s firm about one thing: psychedelics are not a one-and-done fix. “Healing should be multidisciplinary,” she told me. “It’s a buffet. You don’t eat one thing and hope it lasts forever.” That line should be tattooed on the inside of every retreat brochure. Rudy, an 18-year special forces operator, had never touched an illicit drug before his first ayahuasca ceremony. His marriage had collapsed. He’d had an emotional breakdown. The VA had offered him what he called a cornucopia of pharmaceuticals, and he’d watched what those same prescriptions had done to friends. He said no. The symptoms were textbook combat PTSD — waking up convinced he was still deployed, snapping at things that didn’t matter, suffocating in crowds. One night he came back to consciousness standing naked at his own front door with a pistol, certain his teammates were about to be overrun. It was his wife’s voice that pulled him back. He flew out for ayahuasca through a veterans-focused organization. Months later, he didn’t describe himself as fixed. He described himself as having a new template for processing experience. The combat memories are still there. They just don’t run the show anymore. He also, in his words, left several buckets of vomit at the retreat — and joked that the shaman called him a strong purger. That kind of humor, in my experience, is a good sign someone is genuinely on the other side of something. Not every story takes place in a jungle. Lori, 42, was one of the early participants in MAPS’s FDA-cleared MDMA trials. Her trauma history is the kind that breaks sentences in half: her brother’s overdose, a rape by someone she knew, and walking in on the aftermath of a murder-suicide committed by her own mother. She received MDMA in three guided sessions, sandwiched between talk-therapy preparation and structured integration afterward. What she stresses — and what facilitators stress — is that the integration phase is where a lot of the actual healing settles in. The drug isn’t the therapy. The drug opens a window. What you do with what you saw, over the following weeks and months, is the therapy. This is where I see retreats and trials fail people most often. The ceremony is dramatic. The aftermath is quiet. Without integration — journaling, therapy, somatic work, community, time — it’s easy to slide back into old grooves and wonder why the magic didn’t stick. If you’re reading this because you’re weighing a booking, here are the questions I’d want you sitting with before you wire any deposits: I’ll be honest — the psychedelic space attracts both genuine healers and a fair number of opportunists with good lighting. Vet your facilitators the way you’d vet a surgeon. Read participant accounts that aren’t on the retreat’s own website. Talk to people who attended a year ago, not last week — because the year-later picture is what actually matters. A lot of people, understandably, can’t afford a structured retreat or wait years for a trial. Microdosing and underground experiences are everywhere. Researchers in this field — including the ones running the trials — consistently warn that self-medicating powerful compounds without screening, set, setting, or support can surface material people aren’t prepared to hold. That’s not a moral judgment. It’s a practical one. Trauma stored in the body has its own logic. When it comes up uninvited, in a context with no facilitator and no integration, it can entrench rather than release. If you’re going to do this work, give yourself the conditions to do it well. What strikes me about the people in these stories isn’t the drama of the ceremonies. It’s the ordinariness of what they wanted afterward — to sleep through the night, to be present with their kids, to stop bracing against everything. Psychedelics didn’t hand that to them. The medicine cracked something open, and they did the unglamorous work of rebuilding from there. If any of this resonates and you want to take a careful next step, a curated selection of ayahuasca and psychedelic retreats — including options that work specifically with veterans and trauma — can be browsed on our marketplace here. Take your time. The right retreat will still be there next month.
Bufo Alvarius: What a 5-MeO-DMT Ceremony Actually Feels Like
Someone asked me once, very casually, over tea: “You've sat with ayahuasca, you've done kambo — but have you ever smoked the toad?” The way they said it made the question land differently. Like they were quietly checking whether I knew what I was getting into. Bufo, they kept telling me, is something else entirely. Why, I wondered, would anyone willingly sign up to feel like they're dying? And yet here I am, writing about the night I did exactly that. This is a long piece about Bufo alvarius — what the medicine is, where it comes from, what the ceremony looked like from the inside, and what stuck around afterward. If you're researching whether to sit with 5-MeO-DMT yourself, I'd rather you read an honest account than a glossy one. Bufo refers to the dried venom of the Sonoran Desert toad — Bufo alvarius, also called Incilius alvarius by the people who care about taxonomy. The toad lives in a narrow band of desert across northern Mexico and the American Southwest. Its parotid glands secrete a milky substance loaded with tryptamines, the most notable being 5-MeO-DMT, which is widely considered the most potent naturally occurring psychedelic on the planet. The secretions are harvested without killing the animal, then dried into small crystalline flakes. Those flakes get loaded into a glass pipe, gently heated, and inhaled in a single slow breath. The effects arrive almost immediately. Total duration is usually fifteen to twenty minutes by the clock. Inside the experience, time is meaningless. People come back saying it felt like forever, or like no time at all, or both. This is worth pausing on: 5-MeO-DMT is not the same as the N,N-DMT found in ayahuasca. The visual character is different. The emotional terrain is different. Ayahuasca tends to give you a narrative — scenes, memories, conversations with something that feels like an intelligence. Bufo tends to dissolve the narrator entirely. There's no story. There's just whatever is left when the story-maker stops. For a long time my answer was a polite no. The reports I heard sounded too intense, too close to actual ego death, too much like the dying I wasn't ready for. I had two kids at home. I had work I cared about. I wasn't running away from anything obvious, and I couldn't find a clean reason to invite something that felt this big. Then a stranger messaged me about a ceremony happening the following week, on the one open evening between Christmas and New Year — the only unscheduled day in a packed month. I'm not a sucker for coincidence, but my body said yes before my mind could argue. So I went. If you're considering Bufo, I'd offer this: pay attention to how the invitation arrives. Are you chasing it because you've seen testimonials on Instagram and you want what those people seemed to get? Or has it shown up in your life with a strange quiet insistence that you can't quite explain away? Those are different motivations, and they tend to produce different ceremonies. The ceremony was on the top floor of an old building near a canal in Amsterdam. Steep stairs, creaking floors, about ten of us sitting on cushions in a circle. Sage smoke. A small altar with feathers and a few stones. None of it was theatrical. It looked, honestly, like somebody's living room arranged with care. The facilitator — I'll call him Raul — opened by saying he wasn't a shaman. “We're each our own shaman,” he said. “I'm just here to sit with you while it happens.” Every actual shaman I've met says some version of this. The ones claiming the title outright are almost always the ones to avoid. His partner translated from Spanish into English. They explained what the medicine does and doesn't do, what to expect physically, what might come up emotionally, and what they would do if someone struggled. They told us bluntly: the body can feel heavy. The body can feel orgasmic. The ego dissolves. You may not remember who you are. They asked each of us to set an intention. People went one at a time. Raul would load the pipe, heat it, and guide the person to breathe out, then inhale slowly and hold. Within seconds, most of them either lay back voluntarily or were gently lowered to the floor. Then came the next fifteen or twenty minutes — completely different for everyone. Some people went silent and motionless. One person sobbed. One laughed for nearly the entire time. One thrashed for two minutes and then went still and beatific. Raul's response shifted with each — sometimes singing, sometimes waving a feather, sometimes just sitting nearby looking unbothered. There was no formula. He read each person and responded. What surprised me, watching, was how unlike kambo this looked. Kambo is loud — the racing heart, the purging, the heat. Bufo was quieter on the outside. The whole drama was happening internally. That calmed me down a little before my turn. When they called me up, my main fear wasn't death itself. It was leaving my kids without a mother. But everyone in the circle had returned from their own dying, so I figured I could too. I'd later come to think of that moment — the willingness to let go even briefly — as the actual work. The smoke is just the vehicle. The pipe touched my lips. It tasted like singed hair and something organic I'd rather not name. I relaxed my throat and kept drawing it in until Raul said stop. Hold. The drop was immediate. I felt myself fall backward into the floor — into the earth beneath the floor — while a warm, overwhelming light filled my visual field. Behind my eyelids, fractals rushed toward my forehead at speeds I had no reference for. Most were drenched in color. Some were stark black and white. Waves of sensation moved through me that I genuinely have no language for. So this, I thought from somewhere, is what dying feels like. What I learned in those minutes — and this is the only practical thing I can really offer you — is that resistance and surrender produce wildly different experiences inside the same medicine. When my thinking mind tried to assert itself (should I make sounds? should I move?) the colors dimmed and a harsher, more judgmental texture crept in. When I let go and dropped attention back into the fractals, the beauty returned. The choice point was right there, over and over. That's the practice. I sat up, eventually. Raul was in front of me. We held eye contact for what felt like a long, wordless conversation. My mind was already running its usual program — did I do that right? what now? — but underneath it was a quieter knowing that didn't need anything from me. We bowed. He leaned in and said one word in my ear that happened to be the exact word I'd been working with all year. I won't share it. It would mean nothing to you and everything to me. For about a week, I felt soft and porous in the best way. More love in my chest. Easier tears at small things — strangers laughing on a tram, my kid drawing something terrible and showing me proudly. Also, oddly, the world felt slightly flat. The colors of ordinary life were duller, as if I now knew about a dimension that wasn't currently accessible. This is normal. Integration after 5-MeO-DMT can include a kind of homesickness for the state the medicine showed you. Some people report a low or grey period in the second or third week. Some get the opposite — sustained joy, clarity, a quieter inner critic. Most get some of both. If you're thinking about sitting with Bufo, plan your calendar accordingly. Don't book a ceremony the night before a job interview or a wedding you have to host. I can't answer that for anyone else. What I can say is that Bufo is not a beginner medicine, and it's not a substitute for therapy, recovery work, or the long slow building of a life you actually want to be in. It's a brief, extraordinary look at something — call it consciousness, call it presence, call it whatever you want — and what you do with that look is the rest of the work. If you're drawn to it because ayahuasca felt too long, kambo too physical, or psilocybin too narrative — fair enough. If you're drawn because you want a shortcut past your trauma, please reconsider. There are no shortcuts. The medicine can crack open a door; walking through it is still on you. For readers who feel quietly called to take this further, a curated selection of 5-MeO-DMT and broader plant-medicine retreats can be browsed on our marketplace here. Take your time choosing. The right ceremony will still be there when you're ready.
Why Silicon Valley Money Is Pouring Into Psychedelics Startups
Something strange is happening at the intersection of psychedelics and Silicon Valley. The same investors who funded scooter apps and food-delivery platforms are now writing checks to companies developing the next generation of psychedelic-assisted therapies. If you'd told me a decade ago that the world's most famous startup accelerator would be backing magic-mushroom research, I'd have laughed into my mug of mapacho tea. And yet here we are. Analysts have floated numbers north of $100 billion for the future psychedelics market, and the money is moving accordingly. For anyone researching ayahuasca, ibogaine, psilocybin, or other master plants — whether for addiction recovery, depression, or just the kind of stuck life pattern you can't seem to shake — this matters. The infrastructure behind plant medicine is changing fast, and what gets built (or doesn't) over the next five years will shape the retreats, clinics, and protocols you'll eventually choose between. The short answer: clinical results, decriminalization momentum, and an addiction-and-depression crisis that mainstream pharma hasn't dented. SSRIs have plateaued. Opioid overdoses keep climbing. Veterans are dying by suicide at rates that should embarrass everyone. Into that vacuum walks a body of research — much of it from Johns Hopkins, NYU, Imperial College London, and MAPS — suggesting that compounds like psilocybin, MDMA, and ibogaine produce meaningful, sometimes durable improvement after just one or two sessions. Investors smell a fundamental shift. Not incremental. Generational. When something works better than the current standard of care and the regulatory door is creaking open, capital floods in. That's the boring, predictable part. The interesting part is what those investors choose to fund. The famed Y Combinator accelerator — the one that backed Airbnb, DoorDash, and Dropbox before anyone knew their names — has quietly admitted several psychedelics companies to its program. A spokesperson was careful to say YC doesn't pick industries, it picks teams. Fair enough. But the fact that four psychedelics startups cleared a roughly 1.5% acceptance bar tells you something about where smart money thinks the puck is heading. A handful of YC-backed companies give a useful snapshot of the space. None of them run retreats. All of them are building the scaffolding around the medicines themselves. What's striking is the range. One company is building clinical software. Another is doing computational drug design. A third is running traditional pharma R&D with a psychedelic twist. None of them are running ceremonies in the jungle. That distinction matters more than it might seem. Here's where things get philosophically interesting, and where I'll be honest about my own bias. I've sat in ayahuasca ceremonies. I've watched people work through grief, trauma, and addictions that years of talk therapy hadn't budged. The thing that made those experiences powerful wasn't the molecule alone — it was the container. The shaman who knew when to sing and when to be silent. The dieta beforehand. The integration circle the next morning. The jungle itself. Venture-backed psychedelics is a different beast. It's optimized for FDA approval, insurance reimbursement, and scalable clinical delivery. That has real upside: standardized dosing, medical oversight, fewer cowboys offering "ceremonies" in suburban living rooms. It also has real costs. The ceremonial context — the lineage, the songs, the relationship with the plant as a being and not a compound — doesn't fit neatly on a Series A pitch deck. For readers weighing whether to fly to Peru, Costa Rica, or Mexico for a traditional retreat versus waiting a few years for a clinical option closer to home, the trade-offs are worth thinking about honestly: None of these paths is automatically right. What matters is matching the path to what you're actually working with. Someone with treatment-resistant depression and no trauma history might do beautifully in a clinical setting. Someone unwinding decades of complex PTSD or wrestling with addiction often needs the longer arc and ceremonial holding that retreats provide. A hundred billion dollars sounds like it could solve a lot of problems. It won't solve the ones that matter most. It won't teach a facilitator how to sit with someone in their darkest hour without flinching. It won't replicate the apprenticeship of a curandero who learned from their grandmother who learned from hers. It won't undo the extractive history of foreign companies patenting compounds that indigenous people have used for generations. And — this is the quiet part nobody at a pitch meeting wants to say — it won't change the fact that psychedelic healing is hard, often uncomfortable, and absolutely not a shortcut. I've seen people come back from a retreat changed in ways that lasted years. I've also seen people come back convinced they were healed, then quietly relapse six months later because they skipped the integration work. The medicine is not the cure. The medicine cracks something open, and then the actual work begins. No amount of venture funding changes that math. Both. Probably more good than bad, if I'm being fair. Legalization and clinical access mean people who would never travel to the Amazon — veterans, people with chronic illness, people without passports or PTO — will eventually get access to compounds that could genuinely help them. That's worth a lot. The risk is monoculture. If clinical models dominate the conversation, the ceremonial traditions get framed as quaint, unscientific, or unsafe — even when they've been refined over centuries and produce outcomes the studies are only beginning to measure. The best future is one where both exist, where someone can choose a six-day ayahuasca retreat with a vetted lineage or a structured psilocybin protocol at a clinic forty minutes from home, depending on what they need. For readers who want to take this further, a range of curated plant-medicine and psychedelic retreats can be browsed on our marketplace here — useful if you're weighing the traditional side of the equation against the clinical wave that's still a few years out. Whichever path you find yourself drawn to, do the homework. Talk to people who've sat with the specific medicine you're considering. Ask facilitators uncomfortable questions about training, safety protocols, and what happens if something goes wrong. The money rushing in will eventually make this whole landscape safer and more accessible. Until it does, your discernment is the most valuable thing in the room.
The Psychedelic Renaissance: Why Science Is Revisiting Plant Medicines for Addiction and Depression
Something strange has happened over the past decade. Substances that were treated as cultural radioactive waste for half a century — LSD, psilocybin, mescaline, MDMA, ayahuasca — are now being studied at Johns Hopkins, Imperial College London, NYU, and a growing list of universities that wouldn't have touched this work in 1995. Psychedelics and the broader family of master plants are no longer fringe. They're showing up in peer-reviewed journals, in regulatory filings, and in conversations between therapists and clients who have run out of other options. If you're researching a retreat — quietly, maybe a little nervously — you've probably noticed the shift too. The tone has changed. The people writing about plant medicine for addiction recovery aren't all wearing tie-dye. Some of them are clinicians. Some are veterans. Some are recovering executives who tried everything else first. So what actually happened? Why did the science come back, and what does the current evidence really say? Most people forget — or were never taught — that there was a first wave. Between roughly 1950 and the late 1960s, more than a thousand scientific papers were published on psychedelics. Humphry Osmond, the British-Canadian psychiatrist who actually coined the word psychedelic in 1957, was treating alcoholics with LSD and getting results that would make a modern addiction researcher sit up straight. Mescaline, freshly synthesized from the peyote cactus, was being studied alongside Albert Hofmann's LSD, which Sandoz had been distributing to researchers since 1938. Then the door slammed shut. A combination of factors — the CIA's grotesque MK-Ultra mind-control program, Timothy Leary turning Harvard into a self-promotion machine, alarmist government films, and a recreational scene that genuinely did produce casualties — collapsed the entire research field. By 1970, the Controlled Substances Act in the U.S. had placed these molecules in Schedule I, the most restrictive category. Studying them legally became almost impossible. Careers built on that work evaporated. Here's the part that gets glossed over: the science didn't die because the science was bad. It died because the political climate made the science unfundable and the researchers unemployable. Promising data on alcoholism, end-of-life anxiety, and depression simply sat on shelves for decades, waiting. The thaw started slowly. In 2009, Britain's chief drug adviser David Nutt publicly argued that alcohol and tobacco were measurably more harmful than LSD, MDMA, and psilocybin. He was fired. But his data — and the controversy — cracked something open. Other established researchers began publishing again. MAPS (the Multidisciplinary Association for Psychedelic Studies) and the Beckley Foundation kept funding work that universities were too nervous to underwrite directly. The findings that emerged over the next decade and a half are the reason you're reading this article today: None of this means psychedelics are a miracle. It means the evidence base has grown thick enough that ignoring it is no longer intellectually defensible. If there's one thread that keeps surfacing in this work, it's addiction. The early Saskatchewan LSD trials in the 1950s were aimed at alcoholism. Modern psilocybin work has revisited that exact question and found echoes of the same results. Ayahuasca retreats in Peru and Costa Rica are quietly full of people working on alcohol, cocaine, and opioid dependence. Ibogaine, derived from the iboga root in West Africa, has built its underground reputation almost entirely on opioid interruption. Why? The honest answer is that nobody fully knows. The leading theories involve a combination of neuroplasticity — these substances appear to make the brain temporarily more flexible — and the psychological experience itself, which often delivers something that feels like a confrontation with whatever the person has been avoiding. Patients describe seeing the shape of their own behavior from outside it, sometimes for the first time. That's not a mechanism a pharmaceutical company can patent, which may be part of why the research took so long to come back. The takeaway for someone considering plant medicine for addiction: this is a serious avenue worth taking seriously, but it isn't a one-shot cure. The people who get lasting benefit tend to do real preparation, real integration, and real life-restructuring afterward. The ceremony is the doorway, not the destination. Here's where the current renaissance differs from the 1960s in a way that actually matters. The first generation of researchers tried hard to isolate the molecule from its context. That was the dominant scientific instinct of the era — strip away the ritual, the music, the setting, the shaman, and measure the chemical. The randomized controlled trial, which became the gold standard of pharmacology, is built on exactly that logic. It turns out that with psychedelics, you can't really do that. Set and setting — the mindset you bring and the environment you're in — shape the experience more than the dose does, past a certain point. The Indigenous traditions that had been working with ayahuasca, peyote, and psilocybin mushrooms for centuries already knew this. They built elaborate frameworks around the medicine: dietary preparation, songs, intentions, community, aftercare. Modern researchers are, somewhat sheepishly, beginning to admit that those frameworks aren't decoration. They're part of what makes the medicine work. This is why the better retreats today combine clinical seriousness with traditional practice. The facilitators have read the papers and spent years apprenticing with elders. Neither half alone is enough. If you're sitting at your laptop wondering whether to actually do this — book a flight, take time off work, drink something that will reorganize your inner life for a few hours — the science gives you reasons to take the option seriously. It doesn't give you reasons to be reckless. A few things worth thinking through honestly: The psychedelic renaissance is real, the evidence is meaningful, and the door that closed in 1970 is genuinely open again — but as a participant, not just an observer, you're walking into something that asks for respect. For readers who want to explore this further, a thoughtfully curated range of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Take your time. The medicine isn't going anywhere, and neither is the question you're trying to answer.
Aaron Rodgers, Ayahuasca, and What Athletes Are Finding in the Brew
When a four-time NFL MVP says a jungle brew helped him play the best football of his life, people listen. Or at least they click. Aaron Rodgers spent part of his off-season talking openly about drinking ayahuasca in South America, and the quote that made the rounds — that the experience taught him to unconditionally love himself — has been replayed everywhere from sports radio to wellness podcasts. It's a strange sentence to hear from a quarterback. It's also, if you've spent any time around ayahuasca ceremonies, a pretty common one. I've sat in maloca after maloca over the years, interviewed facilitators on three continents, and watched a lot of people walk out of ceremony saying things that would have sounded ridiculous to them a week earlier. So when Rodgers credits ayahuasca with sharpening his game, I don't roll my eyes. But I also don't think his story is the green light some headlines made it out to be. Plant medicine is more interesting, more demanding, and more uneven than a single celebrity testimonial can suggest. On a long-form interview with Aubrey Marcus, Rodgers described the experience as the gateway to a season he called the best of his career. He didn't talk about visions or geometric patterns or the usual psychedelic furniture. He talked about being able to love himself without conditions — and how that, in turn, changed how he showed up for teammates. The football, in his telling, followed the inner work, not the other way around. That framing matters. It's easy to read his comments as “ayahuasca made me a better quarterback,” but he was careful to put the relational piece first. He talked about leadership, about caring before performing, about modeling something for the locker room. Whether or not you buy any of it, it's a more honest description of what people typically report after ceremony than the clickbait version suggests. It's also worth saying: Rodgers has a track record of trying unconventional things. He's done long ayurvedic cleanses involving ghee and a level of dietary discipline most of us couldn't manage for a weekend. The ayahuasca trip wasn't a one-off spiritual tourism stunt. It was one chapter in a longer experiment with how he tends to his nervous system, his attention, and his stress load. Context like that matters when you're trying to figure out whether his experience has anything to teach yours. The brew is made by boiling the Banisteriopsis caapi vine with the leaves of chacruna, which contain DMT. The vine is what makes the DMT orally active — without it, you'd just digest the compound and feel nothing. Indigenous Amazonian peoples have been preparing this combination for a very long time, in ceremonial contexts that involve song, diet, and a trained person holding the space. The drink itself tastes like swamp water that has a personal grudge against you. Most people purge — vomiting, sometimes more — and that's considered part of the work, not a side effect to manage away. The journey itself usually lasts four to six hours. People describe visual landscapes, encounters with what feel like beings or intelligences, and waves of memory and emotion that arrive uninvited. Sometimes the night is gentle. Sometimes it is one of the hardest things you've ever done. The cliché that ayahuasca gives you what you need rather than what you want exists because people keep repeating it after their ceremonies. It's annoyingly accurate. The reason this matters for someone considering a retreat: ayahuasca isn't a recreational drug, and the people who treat it like one tend to have rough nights. It's a long, demanding, often confronting experience. The container around it — the facilitators, the group, the location, the integration support afterward — does a lot of the heavy lifting in determining whether the experience helps you or destabilizes you. This is where the research catches up to the anecdotes, slowly. Clinical trials over the past several years have looked at psilocybin for treatment-resistant depression, MDMA for PTSD, and ibogaine for opioid dependence, with results that have made even cautious researchers raise their eyebrows. Ayahuasca specifically has a smaller but interesting body of research suggesting effects on depression, addiction patterns, and what people loosely call “stuck” thinking. Here's what the honest version of that story sounds like: For people specifically considering plant medicine for addiction, the picture is genuinely promising and genuinely complicated. Ibogaine has the most dramatic short-term results for opioid dependence, but it carries cardiac risks and needs medical screening. Ayahuasca and psilocybin show up in studies on alcohol use disorder and various behavioral addictions, often with strong outcomes when paired with therapy. None of it replaces the long, unglamorous work of actually changing your life. It can, sometimes, give you the leverage to start. The boom in psychedelic retreats has been a mixed blessing. There are facilitators doing extraordinary work — people who trained for years, who run small groups, who follow up with participants months later. There are also operations that charge five figures for a long weekend and have no business serving medicine to anyone. The gap between those two ends of the spectrum is enormous, and the marketing often looks identical. If you're researching a retreat, a few things separate the serious from the sketchy: Celebrity endorsements of psychedelics make me slightly nervous, even when I think the celebrity is being sincere. The reason is simple: when someone famous credits a substance for a transformation, a lot of people hear “I should try that” without hearing the rest of the sentence. Rodgers wasn't recommending ayahuasca to his fans. He was describing his own experience. Those are different things. If his story has piqued your curiosity, the useful question isn't “should I drink ayahuasca?” It's “what am I actually hoping a psychedelic experience will do for me, and is there a path to that which makes sense given my life right now?” For some people, the answer is a well-chosen retreat with a long preparation runway. For others, it's therapy, or a meditation practice, or treating a sleep disorder, or a year of quiet work before any plant medicine enters the picture. The interesting thing about ayahuasca is that it tends to amplify whatever you bring to it. Bring confusion and it can amplify confusion. Bring intention and it can amplify that too. The honest pitch for plant medicine isn't that it's transformative — it's that it can give you a rare, vivid look at yourself, and what you do with that look is the actual work. Rodgers seems to have done something with his. Most people who walk out of ceremony do too, eventually, if they have the support around them to keep going. For readers who want to take this further, a range of vetted ayahuasca and plant medicine retreats can be browsed on our marketplace here. Whether you end up booking one or not, the better outcome is that you make whatever decision you make with your eyes open — about the medicine, the container, and what you're actually walking toward.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
Ayahuasca and Grief: What Prince Harry's Story Reveals About Plant Medicine Healing
A 12-year-old boy loses his mother in one of the most public tragedies of the late twentieth century. He doesn't cry. Not really. Not for years. He grows into a man who carries that silence like a second skeleton — and then, somewhere in his late thirties, he drinks a bitter Amazonian brew under the care of facilitators and something finally gives way. That's the story Prince Harry told a journalist not long ago, and whatever you think of the man or the monarchy, the disclosure mattered. Ayahuasca, once a fringe curiosity, keeps surfacing in the lives of people who've tried everything else. Veterans. Recovering addicts. Therapists. And now a duke. The interesting question isn't whether his experience was real to him — clearly it was — but what it tells the rest of us about plant medicine, grief, and the long shadow of trauma that ordinary talk therapy sometimes can't reach. The short version: he'd convinced himself, somewhere deep down, that crying was the only proof of love he could offer his mother. If he wasn't weeping, he wasn't grieving properly. If he wasn't grieving properly, he was a bad son. That story had been running in the background of his life for decades. Under ayahuasca, with what he called “the proper people” around him, the script collapsed. He described a sudden clarity — that his mother wanted him happy, not theatrically broken. The weight he'd been carrying wasn't an unmet duty to cry. It was the refusal to accept she was actually gone, paired with the belief that joy would somehow betray her memory. That's a remarkably specific insight to come out of a single ceremony. And it's also exactly the kind of insight ayahuasca facilitators hear repeated, in different shapes, from participant after participant. The medicine doesn't give people new information so much as it dismantles the protective stories they've built around old information. Talk therapy is brilliant at many things. Sitting with a grief that's been frozen since childhood is sometimes not one of them. The reason is mechanical, not mystical. When a child experiences something the nervous system can't process — a parent's sudden death, a car crash on a Paris road, a funeral watched by a billion strangers — the body files the experience somewhere language can't easily reach. You can talk about it for years and still feel nothing. Ayahuasca and other psychedelic medicines appear to loosen that filing system. The default-mode network — the part of the brain that runs your familiar self-story on a loop — quiets down. Memories surface with their emotional charge intact, sometimes for the first time. People weep over losses they thought they'd processed. They feel rage they didn't know they were carrying. They forgive people they didn't know they hadn't forgiven. None of this is magic, and it isn't a shortcut either. The medicine opens a door. Walking through it is still the participant's work. Here's where it gets interesting. The clinical research, while still early, keeps pointing in a consistent direction. Studies on ayahuasca-assisted treatment for depression, PTSD, and substance dependence have shown meaningful reductions in symptoms — often after just a handful of ceremonies, and often holding up months later. Observational work with long-term ceremony participants tends to find lower rates of problem drinking and drug use than in matched populations. This isn't proof of a cure. It's proof that something interesting is happening that deserves more research. The combination of DMT and the MAO inhibitors in the ayahuasca vine appears to do something that synthetic psychedelics alone don't quite replicate — a longer, more emotionally textured experience that seems to lend itself to autobiographical work. For people stuck in patterns — the same depressive loop, the same drink at 6 p.m., the same relationship dynamic with three different partners — master plants like ayahuasca, iboga, and psilocybin can break the pattern's grip long enough for a person to see it from the outside. Whether they choose to live differently afterward is, again, on them. Harry mentioned in passing that his ayahuasca experience created distance between him and his older brother. That detail deserves more attention than it usually gets in these stories. Plant medicine changes people. Not always dramatically, not always permanently, but often enough that family members notice. The person who comes home from a retreat sometimes sees old relationships differently. They have less patience for certain dynamics. They want to talk about things the family doesn't want to discuss. They've been somewhere the people they love haven't, and there's no easy way to share the territory. This is one of the genuinely difficult costs of doing this work, and reputable retreats will talk about it during preparation. If you're considering a ceremony, expect that: None of this is a reason not to go. It's a reason to choose carefully and prepare honestly. The phrase Harry used — taking ayahuasca with “the proper people” — is doing a lot of quiet work in that sentence. The difference between a well-run ceremony and a poorly run one is the difference between cathartic and catastrophic. If you're looking at retreats, the questions worth asking are unglamorous and specific: Cost varies wildly, from a few hundred dollars for a single ceremony in a city to several thousand for a week in Peru or Costa Rica. Higher price doesn't guarantee quality, but suspiciously cheap usually means corners cut. You don't need a public tragedy to qualify. Grief doesn't grade itself. A parent who died when you were a child, a divorce you never quite recovered from, a friend lost to suicide, a version of yourself that disappeared somewhere along the way — these are all reasons people end up sitting in ceremony. Two honest cautions, though. First, ayahuasca is not a single dose of healing. People who walk in expecting one night to fix twenty years of pain usually walk out disappointed, or worse, destabilised. The medicine tends to show you what needs work, not do the work for you. Second, the post-ceremony period matters more than the ceremony itself. Plan for it. Take time off afterward. Have a therapist lined up. Don't book a retreat the week before a major work deadline or your sister's wedding. Treat integration as part of the cost, not an afterthought. For readers who want to take this further, a range of vetted ayahuasca retreats can be browsed on our marketplace here. Whether or not booking one ends up being the right call for you, the decision deserves the time you're already giving it.
What Celebrity Ayahuasca Stories Actually Tell Us About Real Ceremonies
Every couple of months, a celebrity comes back from Costa Rica or Peru and tells a late-night host they drank ayahuasca and went to hell. The clip goes viral. The comments split between “sounds horrifying” and “where do I sign up.” And somewhere in the middle, a real person — maybe you — is sitting with a browser tab open, wondering whether any of this applies to their actual life. It's a fair question. Ayahuasca is having a long, loud cultural moment, and the loudest voices in it are not always the most useful ones. So let's take a famous account — the one where Megan Fox described her ceremony in Costa Rica as both “hell” and a “good bonding experience” — and use it as a way into the stuff that actually matters when you're considering a psychedelic retreat for yourself. Fox said she went in thinking the retreat would be “five-star” — some kind of upscale jungle experience with nice sheets and a wellness menu. What she got was the middle of the jungle, no food after 1 p.m., and a maloca full of strangers preparing to drink a bitter brown brew. This is one of the most common mismatches between expectation and reality, and it trips up a lot of first-timers. The retreats getting the most legitimate work done are usually not the ones with infinity pools and turndown service. Traditional plant medicine work tends to be physically simple on purpose. You sleep in a basic cabin. You eat plain food — no salt, no sugar, no oil, no meat, depending on the lineage. You sweat. You sit in silence. The point isn't deprivation as virtue; it's that ayahuasca works on a body and mind that haven't been buffered by comfort all week. If you find yourself comparing retreats and one of them mentions spa treatments and gourmet menus alongside the ceremony schedule, that's worth a second look. Not automatically a red flag — some hybrid places do solid work — but ask the obvious question: what's the dieta, and who's leading the ceremonies? Ayahuasca is a brew, not a single drug. The two essential ingredients are the Banisteriopsis caapi vine and a DMT-containing leaf, usually chacruna (Psychotria viridis). The vine contains MAO inhibitors that allow the DMT in the leaf to become orally active — without that combination, you'd just digest the DMT and feel nothing. This is genuinely one of the more remarkable pieces of ethnobotanical knowledge on the planet, given that the people who figured it out did so without a chemistry lab. The reason this matters for you, the prospective drinker, is that the MAOI component is what creates the dieta requirements you'll read about — no tyramine-rich foods, no SSRIs, no certain medications, no recreational drugs in the lead-up. These aren't optional preferences. Mixing ayahuasca with the wrong substance can be dangerous in ways that have nothing to do with the psychedelic experience. Any retreat worth its salt will send you a detailed medical and dietary screening before they take your deposit. If they don't, walk. Fox described the ceremony beginning with everyone drinking lemongrass tea to induce vomiting together — what she called a “good bonding experience.” For anyone reading this and recoiling: yes, that's a real thing, and yes, it's part of the territory. The traditional word for it is la purga. The purge. Ayahuasca itself frequently induces vomiting, and most lineages frame this not as an unpleasant side effect but as a central feature — the body releasing what the mind has been holding. Some ceremonies open with a separate emetic to clear the system first; others let the brew do that work on its own. Either way, by night two or three, you've stopped being precious about it. Things that are normal during an ayahuasca ceremony and that no one warns you about clearly enough: None of this is failure. All of it is the medicine doing exactly what people have used it to do for centuries. If you go in expecting a clean, dignified, Instagram-friendly experience, you're going to fight the process. Surrendering to the mess is, in a real sense, the work. The most quoted part of Fox's account is the bit about feeling like she was in hell for eternity, with no beginning, middle, or end — and then her ego dying. That phrasing tends to either fascinate people or freak them out. Here's what it actually points to. Ego death, in the psychedelic sense, isn't a metaphor for feeling humble. It's a specific experience where the usual sense of being a continuous self — the narrator in your head — temporarily dissolves. People describe it as terrifying, liberating, or both. The “eternity” language comes from the fact that during these experiences, time doesn't work the way it normally does. Five minutes can feel like a lifetime. There's no clock, no anchor, no exit door you can locate. This is also where the therapeutic potential lives, and why ayahuasca and other plant medicines are being seriously studied for addiction, depression, and trauma. When the usual self goes offline, the rigid stories you tell about who you are and what's wrong with you — the “psychological prison,” to borrow the phrase — can loosen enough that something else becomes possible. People who have been stuck in patterns for decades sometimes report a single ceremony shifting something that years of talk therapy couldn't reach. Sometimes. Not always. Anyone who promises you healing as an outcome is selling, not telling. This is the question worth sitting with. A celebrity describing a difficult-but-meaningful ceremony on a talk show is entertainment. Your decision to spend two thousand dollars and a week of your life on a plant medicine retreat is not. Honest reasons to consider an ayahuasca retreat: Reasons to wait, or to choose something gentler: The plant medicine space has grown faster than its quality controls. There are extraordinary, lineage-rooted centers run by people who have been doing this for decades. There are also opportunists who watched the trend and opened a center last year. Telling them apart requires asking better questions than most websites will answer on their landing page. Some things to ask before you book: If something here speaks to you, the available ayahuasca and plant-medicine retreats can be browsed and booked on our marketplace here. Read carefully, ask the awkward questions, and trust your gut on the answers — the right ceremony at the right time can be quietly life-changing, and the wrong one is mostly just expensive.
What Makes an Ayahuasca Retreat Actually Good? Lessons from a Top-Rated European Center
There's a particular silence at three in the morning inside a ceremony space — the kind you only notice once the icaros have stopped and the kettle in the back is being set for the next round. That silence tells you almost everything you need to know about a retreat. Is it held? Is someone awake? Is the person two mats over being looked after? If you're researching where to drink ayahuasca for the first time, that's the question underneath every other question you're asking. I want to talk about what actually makes an ayahuasca retreat worth your money and your nervous system — using a European center that's been picking up serious recognition lately as a useful reference point. Not to sell you on them. To give you a framework for sizing up any retreat you're considering, whether it's in Peru, the Netherlands, Costa Rica, or a converted farmhouse in Spain. For a long time, the assumption was that if you wanted real ayahuasca you had to fly to the Amazon. That's still a beautiful path, and for some people it's the right one. But over the last decade a handful of European centers — most notably in the Netherlands, where a legal grey area around the brew has been navigated through religious-use frameworks — have built infrastructure that, frankly, some jungle camps can't match. Trained medical support on standby. Multi-day preparation calls. Integration coaches you can actually reach a month later. One of those centers, OMMIJ, was named best ayahuasca retreat in the LUX Resorts and Retreats Awards a couple of years ago, and they've been quietly expanding since — with a second location in Spain joining their original Dutch healing house. The name itself is a play on the Dutch words for to me or about me, which gives you a sense of how they frame the work: not as a spiritual fireworks show, but as a slow return to your own body. Whether or not you ever set foot in one of their ceremonies, the model is worth studying. Because the things they do well are exactly the things you should be looking for everywhere. This is the question I get asked more than any other, and the honest answer is: anywhere from around 400 euros for a weekend in a European setting to 3,000+ dollars for a ten-day immersion in the Sacred Valley. The price spread is enormous, and price alone tells you very little about quality. What you should actually be paying for, regardless of location: A cheap retreat that nails those five things is a better buy than an expensive one that doesn't. A lot of people researching plant medicine right now aren't doing it for curiosity. They're doing it because something in their life has refused to budge — a drinking habit, a depression that hasn't moved despite years of SSRIs, a trauma loop that keeps surfacing in their relationships. Ayahuasca has earned its reputation here partly through clinical research and partly through twenty-plus years of consistent participant reports. The research is genuinely promising. A small but growing body of work — including studies on ayahuasca's effects on treatment-resistant depression — has shown rapid and sometimes lasting reductions in depressive symptoms after a single ceremony. Work on addiction, particularly with stimulant and alcohol dependence, suggests the brew can interrupt craving patterns in ways traditional pharmacology hasn't matched. These aren't fringe findings anymore. They're being taken seriously by researchers at major universities. That said — and this matters — ayahuasca is not a cure. It's a catalyst. People who go in expecting a magical fix tend to come out disappointed or, worse, retraumatized. People who go in willing to do the slow work afterward — therapy, lifestyle changes, integration circles, sometimes more sittings spaced months apart — tend to be the ones telling life-changing stories two years later. The plant shows you the door. You still have to walk through it, hungover and confused, every single day. Skip the YouTube testimonials for a minute. Here's what a typical first night looks like at a well-run retreat. You arrive in the afternoon. There's an intake circle where everyone says, often awkwardly, why they're there. You're given a mat, a bucket (you'll use it; making peace with this is part of the work), water, tissues, a blanket. Lights go down around 8 or 9 pm. The facilitator pours small cups. You drink. It tastes like the inside of an old tree mixed with regret. You sit. Forty minutes pass and you start to wonder if it's working. Then it works. What happens next is wildly individual — some people see geometry, some see nothing visual at all and instead feel decades of held grief move through their chest, some have conversations with parts of themselves they'd forgotten existed. Some throw up and feel reborn. Some don't throw up and feel cheated. The icaros — the medicine songs sung by the facilitator — guide the rhythm of the night. By 2 or 3 am, things soften. People sleep, or sit quietly, or step outside to look at the stars and cry. The next morning there's tea and slow conversation and the strange clarity of having been somewhere you can't quite describe. That's it. That's the whole technology. Everything around it — the diet, the songs, the integration — is what makes the technology work. If you take nothing else from this post, take this list. These are the things that should make you close the browser tab: The good retreats — the ones doing this work seriously, whether they're in Iquitos, Catalonia, or a converted Dutch farmhouse — won't tick any of those boxes. They'll be honest about who shouldn't drink, transparent about their team's background, and almost suspiciously calm about the whole thing. Real medicine work doesn't need to oversell itself. Nobody wants to talk about this part because it isn't glamorous, but it's where retreats either pay off or don't. You'll come home and your partner will ask how it was and you won't have words. You'll be raw for about two weeks. Music will hit different. Old grudges will feel smaller, or much larger, or just suddenly negotiable. Then real life — the inbox, the commute, the in-laws — will reassert itself, and you'll feel the door starting to close. This is the integration window. The retreats that take this seriously will have built you a structure for it: weekly group calls, a private community, a coach you can voice-message. Without that scaffolding, even a profound ceremony tends to fade into a beautiful memory that didn't quite change anything. With it, the small daily shifts compound into something that, a year later, looks like a different life. If you've read this far, you're probably closer to booking than you realized — and the next step is finding a place whose values and practices match what you actually need. A range of vetted ayahuasca retreats across Europe, Peru, Costa Rica, and beyond can be browsed on our marketplace here. Take your time choosing. The right retreat is worth waiting six months for; the wrong one isn't worth a weekend.
Inside the Rise of Luxury Psilocybin Retreats: What You Actually Get for $7,000
Somewhere between the wellness spa weekend and the underground ceremony in a friend-of-a-friend's basement, a new category has quietly taken shape: the luxury psilocybin retreat. Five-figure flights aside, you're now looking at programs in Jamaica, Costa Rica, and the Netherlands that charge anywhere from $3,900 to nearly $7,000 for a week, mushrooms included. The clientele isn't who you'd expect either. It's lawyers, founders, surgeons, mid-career people who've quietly read every Michael Pollan paragraph twice and want to know what the fuss is about — in a setting where nobody is going to call the cops. I've spent enough time around plant medicine and psychedelic spaces to feel both excited and twitchy about this trend. On one hand: more people getting access to real psychedelic healing, in safer settings, with proper integration. That's progress. On the other hand: a lot of money is flooding in, and not all of it is arriving with clean intentions. So let's actually look at what these retreats offer, what they cost, and whether you — sitting there reading this, weighing whether to spend the equivalent of a used car on a week with mushrooms — should consider one. The shorthand is easy: a multi-day program at a private property, usually in a jurisdiction where psilocybin sits in a legal grey or green zone, with screened participants, trained facilitators, and a ratio of staff to guest that would make most yoga retreats jealous. The longer answer is more interesting. These programs are designed less like a vacation and more like a structured therapeutic arc — preparation, ceremony, integration — wrapped inside the trappings of a five-star stay. What you're really paying for is the container. A villa with thirteen rooms tucked away on a river, two pools, organic meals, a maloca or ceremony space that doesn't smell like the last guy's cologne. One facilitator for every three or four guests. Pre-retreat coaching calls. Six weeks of group integration after you've gone home and your boss is wondering why you keep crying during meetings. That's the product. The mushrooms, ironically, are maybe a third of it. Here's where I have to be honest with you, because the entire psychedelic retreat space is starting to develop the same uncomfortable rhetoric the wellness industry mastered years ago — the implication that if you really want to heal, you'll find the money. I don't buy it. Plenty of people have had transformative psychedelic experiences for the cost of a tank of gas. The mushroom doesn't know what you paid for it. What the money actually buys you is risk reduction and follow-through. Specifically: If you have $7,000 and you'd otherwise be eating mushrooms alone in your apartment on a Tuesday, the retreat is probably the better bet. If $7,000 means second-mortgaging something or canceling a year of therapy to afford it, that math gets ugly fast. There are quieter, smaller, more affordable options out there — including community-based circles in legal jurisdictions and lower-cost retreats in Mexico and Jamaica. The luxury version is one tier of a wider menu, not the only entry point. Most reputable luxury retreats are explicit that they're not designed for people in acute mental health crisis. The phrase used inside the industry is "healthy normals" — people whose lives function, who aren't actively suicidal or in psychotic territory, but who feel stuck. Numb. Career on autopilot, marriage on autopilot, evenings disappearing into a glass of wine and a screen. That kind of stuck. These programs also screen for harder stuff: family history of schizophrenia, current medication conflicts, recent major loss. If you're carrying severe trauma or you're in recovery from substance dependence, a generic luxury retreat may not be the right room for you. Ibogaine programs, dedicated trauma-informed psilocybin therapy, or ayahuasca centers with strong medical staff are different animals built for different work. Don't let glossy marketing convince you a five-star villa is equivalent to a clinical setting — it isn't. The honest reader profile, in my experience, looks like this: late thirties to mid-fifties, professionally accomplished, has read at least one psychedelic book, hasn't tripped since college (if ever), wants the experience inside a setting that feels grown-up and safe. If that's you, the luxury retreat category is genuinely built around your nervous system. The structure across reputable programs is remarkably similar, which is reassuring — it suggests the practitioners are talking to each other and converging on what works. A typical arc: Notice how little of that is the trip itself. Maybe twelve hours out of a hundred-and-twenty-hour program. The rest is scaffolding — the thing that determines whether your six hours of altered consciousness becomes a permanent shift or a fading memory you'll bring up at dinner parties for the next year. Not every retreat charging luxury prices is delivering luxury care. As money has poured into the psychedelic space, I've watched programs spring up that are essentially weekend parties dressed in shamanic costume. A few things to look for, and look out for: The good operators welcome scrutiny. They'll send you their facilitator bios, walk you through the medical screening, and tell you who they've turned away and why. If a program won't engage with those questions, your wallet has its answer. The psychedelic retreat industry is growing fast — projections for the broader psychedelic medicine market run into the tens of billions over the next decade. Regulation is shifting too, with Oregon and Colorado already operating legal psilocybin therapy frameworks and several other states inching that direction. The FDA hasn't approved psilocybin for general therapeutic use yet, but clinical trials for depression and end-of-life anxiety have produced results compelling enough that approval feels like a question of when, not if. What this means practically: in five years, the $7,000 luxury retreat in Jamaica may have local equivalents at a fraction of the price. Community-based psilocybin centers, insurance-covered clinical sessions, lower-cost retreats with the same quality of care. The current premium reflects scarcity and legal complexity more than the underlying value of the mushroom or the work. If cost is the only thing keeping you from exploring this, the menu is widening every year. That said, the work itself isn't going to get any easier just because the price drops. Psychedelics aren't a shortcut — they're an accelerant. They show you what's there. The discipline of integrating what they show you, of actually changing the patterns they illuminate, is still on you, retreat or no retreat. The honest answer depends on what you're after. If you're a curious, reasonably healthy person who wants to explore psilocybin in a setting designed not to traumatize you, and you can afford it without financial strain, a well-run luxury retreat is one of the safest, most supported ways to do that work right now. If you're carrying heavier stuff — addiction, severe trauma, treatment-resistant depression — you want a program built specifically for that, not a wellness retreat dressed up as therapy. And if you've read this far and something in you is leaning toward yes, take that seriously. Curiosity that persists past the second article is usually pointing somewhere. For readers ready to look at specific options, a range of vetted psilocybin retreats can be browsed on our marketplace here. Take your time with the choice. The right container matters more than the right price tag.
Psychedelic Research: Landmark Studies on Plant Medicine and the Brain
If you're reading this, you've probably already gone past the point of casual curiosity. Maybe a friend came back from Peru looking lighter than you'd seen them in years. Maybe you've read about ibogaine clinics in Mexico treating opioid dependence when nothing else worked. Maybe you're tired — quietly, persistently tired — and you want to know whether the buzz around psychedelics is real science or wishful thinking. Good news: there's actual research. A lot of it. Psychedelic research has been quietly accumulating since the early 2000s, and the findings around ayahuasca, psilocybin, MDMA, and the broader family of master plants are genuinely interesting. Not miracle-cure interesting. Not influencer-promising-enlightenment interesting. But solid, peer-reviewed, this-deserves-attention interesting — especially for people thinking about addiction recovery, trauma, or the kind of depression that hasn't budged for years. Here's a tour through the studies that matter, what they actually found, and what it means for someone weighing a retreat. Psychedelic science had a strange century. In the 1950s and 60s, researchers ran thousands of studies on LSD — looking at it as a tool for psychotherapy and, notably, as a treatment for alcoholism. Some of the results were striking. Then 1970 happened. The Controlled Substances Act made the compounds illegal in the United States, funding dried up, and for roughly three decades the field went dark. What we now call the psychedelic renaissance kicked off in the 1990s, when a US-approved study by Rick Strassman cracked the door back open. Everything that follows happened in the last 30 years, much of it in the last ten. That's worth remembering when someone tells you psychedelic healing is "ancient wisdom now proven by science." The wisdom is ancient. The science is young, and still finding its footing. Strassman administered roughly 400 doses of DMT to about 60 participants between 1990 and 1995 at the University of New Mexico. What people reported was strange enough that he ended up calling DMT "the spirit molecule" in his 2001 book of the same name. Participants described visions, intense emotion, out-of-body states, and — this is the part that still raises eyebrows — apparent contact with entities that felt independent of their own minds. Fast forward to 2019. Researchers at Imperial College London ran the first proper brain imaging study on DMT, measuring electrical activity with EEG. They found that DMT suppresses the brain waves associated with normal waking consciousness while ramping up the waves typically seen during dreaming. The participants weren't asleep. They were in what the researchers described as a waking dream — eyes closed, fully conscious, brain doing something it doesn't usually do. This matters for anyone considering an ayahuasca ceremony, because DMT is the visionary component of the brew. Whatever you've heard about journeys, the underlying neurology is real and increasingly mappable. Two studies stand out here. The first, from Dennis McKenna and Charles Grob in 1996, looked at long-term members of the União do Vegetal — a Brazilian religious group that drinks ayahuasca ceremonially. Compared to a control group with no plant-medicine history, the UDV members showed lasting shifts in personality: more emotional steadiness, more optimism, fewer inhibitions, more outgoingness. Several members had struggled with alcohol or depression before joining. After regular ceremonial use, those issues had largely resolved. The second is a 2018 Brazilian study on treatment-resistant depression. Participants who hadn't responded to conventional antidepressants experienced rapid improvement after a single ayahuasca session — and the researchers found that the brew reduces activity in the default mode network, a brain region known to be hyperactive in depressed people. That's a real mechanistic clue, not just a vibe. None of this means you should book a flight to Iquitos tomorrow. But if you've been wondering whether the addiction-recovery and depression stories around ayahuasca have any scientific weight, the honest answer is: yes, some, and it's growing. Roland Griffiths at Johns Hopkins ran a 2006 study that's now considered foundational. Participants who took psilocybin under controlled conditions frequently rated the session as one of the five most meaningful experiences of their lives — comparable, many said, to the birth of a child or the death of a parent. Years later, the meaning was still there. A 2011 study by Grob then showed psilocybin could meaningfully reduce anxiety in patients with advanced-stage cancer. End-of-life dread is one of the cruelest things a person can face, and standard medications often do little. A guided psilocybin session, repeatedly, seems to help people make peace with their mortality — months after the substance is long out of their system. Then in 2017, Robin Carhart-Harris and colleagues at Imperial College published work showing that two doses of psilocybin could rapidly lift treatment-resistant depression. They described it as something like a reset. Improvements held for up to six months. The researchers were also careful to note something that anyone considering a retreat should hear clearly: the quality of the experience predicted the antidepressant effect. Set, setting, and integration aren't decorative add-ons. They're part of the medicine. This is where it gets technical, but stick with me — it's worth knowing. In 1998, Franz Vollenweider's lab in Zurich showed that LSD and psilocybin produce their effects by binding to a specific serotonin receptor called 5-HT2A. When researchers blocked that receptor with another drug, the psychedelic effects didn't happen. That single finding established the neurochemical anchor for most of the classic psychedelics. Carhart-Harris's group then built on this in two ways. First, in 2014, they showed that psilocybin dramatically increases communication between brain regions that don't usually talk to each other — possibly explaining experiences like synesthesia (tasting color, hearing shapes, that sort of thing). Second, in 2016, they captured the first images of a brain on LSD and found that the drug quiets the default mode network, the system associated with our sense of self. When the DMN goes quiet, the ego loosens. That's the neural correlate of what people in ceremony describe as oneness, dissolution, or the experience of being something larger than themselves. If you've ever wondered why people come back from a psychedelic retreat saying things like "I'm not who I thought I was," this is part of the answer. For a few hours, the brain network most responsible for maintaining "who you are" goes offline. MDMA isn't a classic psychedelic — it works on different receptors and produces a different kind of experience. But Michael Mithoefer's 2011 study showed that MDMA-assisted therapy was both safe and effective for people with treatment-resistant PTSD. Combat veterans, survivors of abuse, people who'd tried every other approach — many of them experienced significant, lasting reductions in symptoms after just a few therapy sessions paired with MDMA. The mechanism seems to involve a temporary reduction in fear response, which allows participants to revisit traumatic memories without being overwhelmed by them. The therapy does the work. The medicine creates the conditions. A few honest takeaways from sitting with this body of research: None of this is meant to push you toward a booking. The decision to drink ayahuasca, sit with psilocybin, or work with any master plant is a serious one — and the research, encouraging as it is, doesn't override the need for careful self-assessment. Talk to your doctor about medication interactions (SSRIs and ayahuasca are a known concern). Be honest about your mental health history. Pick a place that screens you back. For readers who want to take this further, a curated selection of ayahuasca and psychedelic retreats can be browsed on our marketplace here — useful if you want to see what reputable facilitators actually offer rather than guess from a Google search. The research is encouraging. The medicine is powerful. The decision is yours to make slowly, with as much information as you can gather.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
